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Productive rearrangement of the immunoglobulin
heavy-chain locus triggers a major developmental
checkpoint that promotes limited clonal expansion
of pre-B cells, thereby culminating in cell-cycle arrest
and rearrangement of light-chain loci. By using Irf4/
Irf8/ pre-B cells, we demonstrated that two path-
ways converge to synergistically drive light-chain
rearrangement, but not simply as a consequence of
cell-cycle exit. One pathway was directly dependent
on transcription factor IRF-4, whose expression was
elevated by pre-B cell receptor signaling. IRF-4 tar-
geted the immunoglobulin 30Ek and El enhancers
and positioned a kappa allele away from pericentro-
meric heterochromatin. The other pathway was trig-
gered by attenuation of IL-7 signaling and activated
the iEkenhancer viabindingof the transcription factor
E2A. IRF-4 also regulated expression of chemokine
receptorCxcr4 andpromotedmigration of pre-Bcells
in response to the chemokine ligand CXCL12. We
propose that IRF-4 coordinates the two pathways
regulating light-chain recombination by positioning
pre-B cells away from IL-7-expressing stromal cells.
INTRODUCTION
Multiple cis-acting elements and trans-acting factors control the
developmentally regulated accessibility of Ig gene segments to
the recombinase machinery (Schlissel, 2004). In differentiating
pro-B cells, productive rearrangement of the Ig heavy-chain lo-
cus leads to the assembly of the pre-B cell receptor (pre-BCR)
(Geier and Schlissel, 2006). Signaling through the pre-BCR and
the IL-7 receptor (IL-7R) drives proliferation and enables clonal
expansion of pre-B cells. Intriguingly, pre-BCR expression re-
duces the dependence of developing B cells on IL-7 signaling
(Milne and Paige, 2006; Rolink et al., 2000). Consistent with thesefindings, pre-B cells are positioned away from IL-7-expressing
stromal cells in the bone marrow (Tokoyoda et al., 2004). Upon
cessation of proliferation, cells transit into the small pre-B cell
stage and induce Ig light-chain recombination. Despite consid-
erable work, the integration of these signaling pathways and their
coupling to nuclear regulators of Ig light-chain recombination
remain poorly understood.
Contrasting arguments have been advanced concerning the
requirement for acquired pre-BCR or attenuated IL-7 signaling
in activating Ig light-chain recombination. Signaling by the pre-
BCR is widely considered to promote light-chain recombination.
As such, enforced expression of a rearranged Igh transgene
increases Igk locus accessibility in RAG-deficient pro-B cells
(Stanhope-Baker et al., 1996). Additionally, expression of a con-
stitutively active Ras protein, a signaling molecule downstream
of the pre-BCR, promotes light-chain recombination in the ab-
sence of a rearranged heavy-chain (Shaw et al., 1999), whereas
loss of downstream components of the pre-BCR signaling
cascade, including BLNK, Btk, and PLCg, results in fewer cells
that are able to rearrange their kappa loci (Flemming et al.,
2003; Xu et al., 2007). However, pro-B cells can undergo Igk
rearrangement in the absence of a pre-BCR (Grawunder et al.,
1993). Therefore, the developmental requirement of the pre-
BCR and themolecular pathway bywhich it promotes light-chain
recombination remain unresolved. Similarly, the role of attenu-
ated IL-7 signaling in the promotion of light-chain recombination
is unclear. Although withdrawal from IL-7 leads to increased Igk
recombination in vitro, Igk rearrangement can be detected in
pre-BCR+ cells that are cultured in a high concentration of IL-7
(Rolink et al., 2000). It has been argued that IL-7 withdrawal
merely leads to the selective survival of IgM+ cells that have
undergone productive light-chain rearrangement (Milne et al.,
2004). Paradoxically, the only established role for IL-7 signaling
in controlling recombination of immunoglobulin loci involves
positive regulation of distal VH gene accessibility via the tran-
scription factor Stat5 (Bertolino et al., 2005). Thus, it remains to
be established whether IL-7 signaling negatively regulates Ig
light-chain locus accessibility, and if so, then the underlying
mechanism is of considerable interest.Immunity 28, 335–345, March 2008 ª2008 Elsevier Inc. 335
Immunity
Developmental Control of Ig Gene RecombinationThe Igk locus contains two distinct transcriptional enhancers,
the intronic enhancer (iEk) and the 30 enhancer (30Ek) that func-
tion to regulate V(D)J recombination. Igk recombination is dimin-
ished upon deletion of either enhancer and completely abolished
in the compound-mutant mice (Inlay et al., 2002). The transcrip-
tion factors E2A and Pax5 are required for Igk rearrangement
(Lazorchak et al., 2006; Sato et al., 2004). However, each of
these factors also regulates heavy-chain rearrangement at the
pro-B cell stage. Therefore, it is unclear how these factors selec-
tively promote Igk rearrangement at the pre-B cell stage. In con-
trast, the related interferon regulatory factor (IRF) family mem-
bers IRF-4 and IRF-8 have been demonstrated to be uniquely
required for Ig light-chain recombination. Irf4,Irf8 compound-
mutantmice accumulate in their bonemarrow cycling pre-B cells
that fail to undergo light-chain recombination (Lu et al., 2003). Al-
though IRF-4 and IRF-8 act in a redundant manner at the pre-B
cell stage, IRF-4 functions exclusively later in B cell development
to regulate Ig class-switch recombination and plasma cell differ-
entiation (Klein et al., 2006; Sciammas et al., 2006). Intriguingly,
in both pre-B and B cells, IRF-4 seems to function to limit clonal
expansion and promote differentiation processes that involve re-
combination and expression of Ig genes (Lu et al., 2003; Sciam-
mas et al., 2006). In both developmental stages, Irf4 expression
is induced downstream of the antigen receptor (Matsuyama
et al., 1995; Muljo and Schlissel, 2003). We therefore considered
the possibility that upregulation of IRF-4 expression at the pre-B
cell stage could be used to trigger Ig light-chain recombination.
We have utilized Irf4/Irf8/ pre-B cells, which represent
a unique experimental system, to analyze the roles of the pre-
BCR and IL-7 signaling pathways in the activation of light-chain
recombination. We demonstrate the existence of two distinct
molecular pathways that function synergistically to promote Ig
light-chain rearrangement. One pathway was strictly dependent
on IRF-4, which targets the 30Ek and El enhancers. The other
pathway was triggered by attenuation of IL-7 signaling and
resulted in activation of the iEk enhancer via binding of the tran-
scription factor E2A. Intriguingly, IRF-4 regulated the expression
of Cxcr4 and promoted the migration of pre-B cells in response
to the chemokine CXCL12. IRF-4 can therefore position pre-B
cells away from IL-7-expressing stromal cells. We propose
that IRF-4 regulates Ig light-chain recombination by coordinating
two molecular pathways that are triggered by acquired pre-BCR
and attenuated IL-7 signaling, respectively.
RESULTS
IgkRecombination CanBe Induced via Two Independent
Pathways in Irf4/Irf8/ Pre-B Cells
Irf4/Irf8/ pre-B cells can be propagated in culture on OP9
stromal cells with the cytokine IL-7 (Lu et al., 2003). The mutant
pre-B cells express both the pre-BCR and the IL-7 receptor and
therefore provide a unique experimental system for analyzing the
role of each signaling pathway in regulating the induction of Ig
light-chain gene rearrangements. By using an IRF-4 antibody,
we noted that IRF-4 protein is elevated in pre-B cells (Figure S1
available online), consistent with elevated Irf4 transcripts seen at
this developmental stage (Muljo and Schlissel, 2003). Increased
IRF-4 expression appears to require signaling through the pre-
BCR because it is dependent on the adaptor protein SLP-65336 Immunity 28, 335–345, March 2008 ª2008 Elsevier Inc.(Thompson et al., 2007). Therefore, restoring expression of
IRF-4 in the mutant cells should enable their pre-BCR-depen-
dent differentiation. Irf4/Irf8/ pre-B cells were transduced
with either a control or an IRF-4 expressing retrovirus. After 3
days, GFP+ cells were isolated and analyzed for Igk locus recom-
bination. We noted that IRF-4 was expressed in these cells at
levels similar to that observed in wild-type pre-B cells
(Figure S1). Importantly, IRF-4 induced Vk recombination to all
four functional Jk gene segments (Figure 1A).
To determine whether diminished IL-7 signaling can indepen-
dently induce Igk recombination, we cultured Irf4/Irf8/ pre-B
cells in media containing varying concentrations of IL-7 (data not
shown). Lowering the IL-7 concentration to 0.1 ng/ml (IL-7lo) re-
sulted in loss of phosphorylated Stat5, a component of IL-7 sig-
naling, and impaired expression of the Cish gene, a Stat5 target
(Figure S2). Surprisingly, we also detected efficient recombina-
tion of Vk gene segments to all four Jk segments upon lowering
IL-7 concentration (Figure 1A). Importantly, Igk recombination
was inducible within 48 hr of attenuating IL-7 signaling under
conditions of minimal cell death (Figure 1B and data not shown).
This suggests that it is a direct consequence of this perturbation
and does not represent selective survival of B lineage cells that
have undergone productive Igk rearrangement. We note that
IRF-4-induced Igk light-chain recombination occurs in the pres-
ence of a high concentration of IL-7 (5 ng/ml), thereby demon-
strating that IRF-4 can promote Igk recombination independently
of attenuated IL-7 signaling (Figure 1A). Collectively, these data
suggest that two distinct pathways can induce Igk light-chain
recombination in pre-B cells: one that is strictly dependent on
IRF-4, a pre-BCR inducible transcription factor, and the other
on attenuated IL-7 signaling.
IRF-4 Expression and Attenuation of IL-7 Signaling
Function Synergistically to Promote Igk Recombination
and IgM Expression
To determine whether these pathways can function synergisti-
cally, Irf4/Irf8/ pre-B cells transduced with the control or
the IRF-4 retrovirus were cultured in high or low concentrations
of IL-7. When both pathways were engaged, there was a greater
than additive increase in the frequency of Igk recombination
(Figure 1B). After productive recombination, transcription of the
rearranged light-chain gene results in the expression of a protein
that pairs with the heavy-chain and is expressed on the cell sur-
face. As expected, expression of IRF-4 in Irf4/Irf8/ pre-B
cells induced the generation of IgM+ B cells in the presence of
high IL-7 (1.8%, Figure 1C). Intriguingly, upon the attenuation
of IL-7 signaling, despite similar amounts of Igk DNA recombina-
tion, Irf4/Irf8/ cells did not give rise to IgM+ B cells. However,
the combination of IRF-4 re-expression and attenuation of IL-7
signaling resulted in a large increase in the frequency of genera-
tion of IgM+ B cells (7.7%, Figure 1C). Therefore, IRF-4 expres-
sion and attenuated IL-7 signaling function synergistically not
only to induce Igk light-chain recombination but also to promote
the generation of IgM+ B cells.
Cell-Cycle Exit Is Not Sufficient to Induce Igk
Recombination in Pre-B Cells
Upon lowering of IL-7 concentration, Irf4/Irf8/ pre-B cells
stop proliferating as indicated by the decrease in forward scatter
Immunity
Developmental Control of Ig Gene RecombinationFigure 1. Igk Recombination Is Induced in Irf4/Irf8/ Pre-B Cells via Two Independent Pathways
(A) Semiquantitative PCR analysis of Igk rearrangements in Irf4/Irf8/ cells transduced with control (MigR1) or IRF-4 retroviral vectors. GFP-sorted cells were
cultured in 5 ng/ml of IL-7 (IL-7hi) for 3 days. IL-7 signaling was attenuated in Irf4/Irf8/ pre-B cells by culturing in 0.1 ng/ml of IL-7 (IL-7lo) for 3 days. DNA from
splenic IgM+ B cells was used as the positive control. PCR reactions employed a degenerate Vk primer and Igk intron primer (primers ‘‘a’’ and ‘‘b’’). We amplified
a region upstream of the Igk intron to control for amount of genomic DNA (primers ‘‘c’’ and ‘‘b’’). Amplified products with 3-fold template dilutions were detected
by hybridization with an Igk intron probe. Data are representative of five independent experiments that utilized three independently derived Irf4/Irf8/ pre-B
cell lines. A schematic of the Igk locus including primers and probes is depicted (not to scale).
(B) Igk rearrangements involving Jk1were assayed under the indicated conditions byQ-PCR andmeasured relative to recombination frequency in IgM+ splenic B
cells. We used amplification of iEk to control for amount of DNA.
(C) Generation of surface IgM+ B cells from Irf4/Irf8/ cells. The mutant cells were transduced with control or IRF-4 retrovirus and then cultured in either IL-7hi
or IL-7lo for two additional days. FACS plots of IgM versus forward scatter are shown after gating on live GFP+ cells. All experiments were performed at least twice,
and representative ones are shown. Error bars in (B) indicate the standard deviation.by FACS (Figure 1C). Interestingly, a similar decrease is ob-
served in a subset of IRF-4-transduced cells, and these are the
cells that become IgMpositive. To directly analyze cell-cycle sta-
tus upon IRF-4 expression or attenuation of IL-7 signaling, we
stained cells with the DNA-intercalating dye, Hoechst. IRF-4 ex-
pression led to an increase in the percentage of cells in G0/G1
(Figure 2A, top panel). Attenuation of IL-7 signaling resulted in
a more pronounced accumulation of cells in G0/G1 (Figure 2A,
bottom panel). These observations raised the possibility that
both pathways induce light-chain recombination in Irf4/Irf8/
pre-B cells as a consequence of triggering cell-cycle arrest. This
hypothesis predicted that inhibiting proliferation of Irf4/Irf8/
pre-B cells, via perturbation of cell-cycle regulators, should
result in the induction of light-chain recombination. We tested
this hypothesis in vivo as well as in vitro. The proliferation of
wild-type pre-B cells is primarily dependent on cyclin D3 (Cooperet al., 2006). As expected, Irf4/Irf8/ pre-B cells proliferating
in the presence of IL-7 expressed high amounts of cyclin D3 and
low amounts of the cell-cycle inhibitor p27 (Figure 2B). Upon
attenuation of IL-7 signaling, cyclin D3 amounts are strongly re-
duced, whereas p27 amounts increase, and the cells arrest in
G0/G1. To genetically test the forementioned hypothesis, we
generated Irf4/Irf8/Ccnd3/ compound-mutant mice. De-
spite the fact that the Irf4/Irf8/Ccnd3/ mice had a higher
proportion of pre-B cells in G0/G1, we detected no Igk light-
chain recombination or a rescue of the B cell developmental
defect (Figure 2C and data not shown). We also tested whether
enforced expression of p27 in cycling Irf4/Irf8/ pre-B cells
would induce light-chain recombination. Irf4/Irf8/ cells
were transduced with either the control or the p27 retrovirus,
sorted 2 days later, and analyzed for Igk recombination. The
p27-transduced cells accumulated in G0/G1 but did not induceImmunity 28, 335–345, March 2008 ª2008 Elsevier Inc. 337
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Developmental Control of Ig Gene RecombinationFigure 2. Cell-Cycle Arrest Is Not Sufficient to Induce Igk Rearrangement in Irf4/Irf8/ Pre-B Cells
(A) Cell-cycle analysis of Hoechst-stained Irf4/Irf8/ cells under the indicated conditions. Transduced cells were analyzed 3 days after culture in IL-7hi
conditions. Samples were gated for GFP expression. IL-7lo cells were assayed 1 day after transfer from IL-7hi conditions.
(B) Immunoblot analysis of cell-cycle regulators in Irf4/Irf8/ cells cultured in IL-7hi or IL-7lo for 2 days. Protein expression was normalized to b-actin.
(C) Cell-cycle analysis of B220+, CD43, and CD25int pre-B cells from Irf4/Irf8/ or Irf4/Irf8/Ccnd3/mice. Semiquantitative PCR analysis of Igk recom-
bination (as described in Figure 1A) in pre-B cells from Irf4/Irf8/ mice is shown.
(D) Cell-cycle analysis of Irf4/Irf8/ pre-B cells after 1 day subsequent to transduction with control or p27 vector. Igk recombination was assayed 2 days after
transduction by Q-PCR as described in Figure 1B (‘‘n.d.’’ stands for not detectable). Data are representative of at least two independent experiments.rearrangement of their Igk light-chain loci (Figure 2D). Thus, cell-
cycle arrest is not a sufficient developmental trigger for inducing
Ig light-chain recombination in pre-B cells.
IRF-4 Expression and Attenuation of IL-7 Signaling
Differentially Induce Germline Igk and Rag1 transcripts
In order tomolecularly analyze themeans bywhich the two path-
ways induce Ig light-chain recombination, we initially focused on
the activation of Igk germline and Rag gene transcription. The
former is tightly correlated with the potential to undergo recom-
binationand isconsidered to reflect a Igk locus that is accessible to
the recombinase machinery (Schlissel, 2004). Irf4/Irf8/ pre-B
cells have a profound block in Igk germline transcription (Lu
et al., 2003). Restoration of IRF-4 expression in the mutant pre-B
cells induceda robust increase in Igkgermline transcription toade-
gree similar to that seen in wild-type small pre-B cells (Figure 3A
and Figure S3A). Attenuation of IL-7 signaling also resulted in acti-
vation of Igk germline transcription albeit at amounts 5%–10% of338 Immunity 28, 335–345, March 2008 ª2008 Elsevier Inc.those observedupon IRF-4 expression (Figure 3A). Thus, although
both pathways modulate accessibility of the Igk locus, IRF-4 is
a more potent inducer of Igk germline transcription.
Irf4/Irf8/ pre-B cells are also impaired for the expression of
theRag genes. In contrast to the pattern observed for Igk germline
transcription, Rag1 transcription was modestly induced by IRF-4
(3- to 4-fold) expression but highly induced upon attenuation of
IL-7 signaling (100-fold) (Figure 3B), although this amount of in-
duction issomewhat lower than found inwild-typesmall pre-Bcells
(Figure S3B). A similar pattern was observed with the Rag2 gene,
although the induction ratios were lower (data not shown). It is im-
portant tonote that the robust inductionofRag1 transcription upon
attenuation of IL-7 signaling is not simply a consequence of cell-
cycleexit because the IRF-4- orp27-transducedcells exhibitmod-
est increases inRag1 transcription (Figure 3Banddatanot shown).
To determine whether engagement of both pathways resulted
in synergistic increases in Igk germline or Rag1 transcription, we
analyzed cells that had been transduced with either control or
Immunity
Developmental Control of Ig Gene RecombinationIRF-4 retrovirus and shifted to the low concentration of IL-7.
Interestingly, we did not observe a synergistic effect on Igk germ-
line or Rag1 transcription (data not shown). Thus, the IRF-4 path-
way preferentially induces Igk germline transcription, whereas
modulating IL-7 signaling more potently activates Rag gene
expression. Therefore, the synergistic increase in Igk recombina-
tion as a consequence of engaging both pathways (Figure 1B) is
partly attributable to their differential effects on locus accessibil-
ity and Rag gene expression (see below).
IRF-4 Counteracts Association of an Igk Allele
with Pericentromeric Heterochromatin
In pro-B cells, both Igk alleles are repositioned away from the
nuclear periphery, and such relocation has been suggested to
promote accessibility to recombination (Kosak et al., 2002).
However, in pre-B cells, one of the Igk alleles becomes associ-
ated with pericentromeric heterochromatin (Goldmit et al.,
2005), a process that has been suggested to favor rearrangement
of the allele that is positioned away from pericentromeric hetero-
chromatin. We used 3D fluorescence in situ hybridization to an-
alyze the positioning of germline Igk alleles in Irf4/Irf8/ pre-B
cells. Intriguingly, these cells displayed a high proportion of nu-
Figure 3. IRF-4 Expression and Attenuation of IL-7 Signaling Differ-
entially Induce Igk Germline and Rag1 Transcription
Indicated RNA transcripts were analyzed by Q-PCR relative to b2-microglobu-
lin in Irf4/Irf8/ pre-B cells after transductionwith IRF-4 retrovirus or shifting
to IL-7lo conditions (1–3 days). As shown in (A), quantitation of Igk germline
transcripts initiated from the Jk proximal promoter. As shown in (B), Rag1
transcripts are represented as fold induction either upon lowering IL-7 concen-
tration (IL-7lo relative to IL-7hi) or upon IRF-4 transduction (IRF-4 relative to
control). ‘‘a.u.’’ denotes arbitrary units. Data represent an average of six exper-
iments. Error bars indicate standard deviation.clei in which both Igk alleles were associated with pericentro-
meric heterochromatin (Figure 4). This is in contrast to
CD19+IgM wild-type B lineage cells or sorted pre-B cells in
which only a small proportion of nuclei displayed biallelic associ-
ation (Figure 4 andGoldmit et al. [2005]). The atypical association
of Igk alleles with heterochromatin in Irf4/Irf8/ pre-B cells did
not change upon lowering IL-7 signaling. These data raised the
possibility that IRF-4 participates in positioning one Igk allele
away from pericentromeric heterochromatin. We therefore ana-
lyzed the nuclear configuration of Igk alleles in Irf4/Irf8/ pre-B
cells after restoration of IRF-4 expression. Importantly, in IRF-
4-transduced cells, a low proportion of nuclei displayed biallelic
association, and thus their nuclear distribution of Igk alleles was
similar to that of wild-type cells (Figure 4). These data demon-
strate that IRF-4 functions in positioning an Igk allele away
from pericentromeric heterochromatin.
Recombination of the Igl Locus Is Dependent on IRF-4
Irf4/Irf8/ pre-B cells are also deficient in Igl germline tran-
scription and recombination (Lu et al., 2003). Therefore, we
sought to determine the effects of both pathways on Igl germline
transcription and recombination. Strikingly, whereas restoration
of IRF-4 expression induced both Igl germline and rearranged
Igl transcripts, attenuation of IL-7 signaling did not appreciably
activate these processes (Figure S4). Therefore, IRF-4 is re-
quired for the activation of Igl germline transcription as well as
recombination.
IRF-4 Expression and Attenuation of IL-7 Signaling
Induce Histone H4 Hyperacetylation at Distinct Ig
Light-Chain Enhancers
Onemajor difference between Igl and Igk loci is their enhancers.
The Igl locus has two duplicated enhancers, each of which has
a functional Ets-IRF composite binding site for IRF-4,8 (Eisen-
beis et al., 1995). In contrast, the Igk locus has two distinct en-
hancers, the intronic enhancer (iEk) and the 30 enhancer (30Ek);
only the latter contains a functional Ets-IRF composite binding
site for IRF-4,8 (Pongubala et al., 1992). Because Igl recombina-
tion is highly dependent on IRF-4, we hypothesized that IRF-4
promotes recombination of Igk and Igl loci via direct engage-
ment of the 30Ek and El enhancers, respectively. In contrast,
we reasoned that attenuated IL-7 signaling may selectively
induce Igk recombination via activation of the iEk enhancer. In
support of this idea, the Jk usage observed in Irf4
/Irf8/
pre-B cells upon inducing recombination by lowering IL-7 signal-
ing (Figure S5) mimics the usage in 30Ek null cells (Inlay et al.,
2002). To test these hypotheses, we assessed the activity of
the endogenous enhancers in Irf4/Irf8/ pre-B cells by ana-
lyzing their chromatin status. Histone-H4 acetylation levels
were measured by chromatin immunoprecipitation (ChIP). The
EL4 T cell line and Rag1/ pro-B cell line were used as controls.
The germline Igk and Igl alleles in EL4 cells were transcriptionally
inactive (data not shown) and exhibited background histone H4
acetylation (Figure S6). In contrast, pro-B cells had a substantial
degree of H4 acetylation associated with the light-chain en-
hancers. Consistent with the hypothesis that IRF-4,8 regulate
the activities of the 30Ek and El1-3 enhancers, the degree of his-
tone acetylation at these enhancers was severely compromised
in Irf4/Irf8/ pre-B cells (Figure S6). We next determinedImmunity 28, 335–345, March 2008 ª2008 Elsevier Inc. 339
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Developmental Control of Ig Gene RecombinationFigure 4. IRF-4 Promotes Positioning of One Igk Allele Away from Pericentromeric Heterochromatin
(A) Three-dimensional FISH analysis of Igk alleles in Irf4/Irf8/ pre-B cells with probes to Vk24 (red), Ck (green), and g-satellite (blue). Both alleles were scored
for association with pericentromeric heterochromatin as determined by colocalization of the Igk and g-satellite signals. An example of each configuration is
shown. Each allele within a single nucleus is shown in a distinct confocal section.
(B) Quantitative analysis of Igk locus association with pericentromeric heterochromatin under the indicated conditions: Irf4/Irf8/ cells cultured in IL-7hi and
IL-7lo (1 day) conditions or transducedwith IRF-4 retrovirus (2 days) after culture in IL-7hi. Igk nuclear configurations are compared to those in CD19+IgM cultured
in IL-7lo. Greater than 70 nuclei were scored for each condition. Black- and gray-shaded regions denote monoallelic and biallelic association, respectively.whether IRF-4 expression could restore histone acetylation at
30Ek and El1-3. Histone H4 acetylation increased in response
to IRF-4 at the 30Ek and El1-3 enhancers (4-fold and
2.5-fold, respectively; Figure 5A). Importantly, no change in
histone acetylation was seen at iEk under these conditions, dem-
onstrating that IRF-4 selectively activates 30Ek and El1-3.
To test whether lowering of IL-7 signaling preferentially in-
duces the activity of iEk, we compared the degree of H4 acety-
lation at Igk and Igl enhancers in the presence of either high or
low concentrations of IL-7. As predicted by our hypothesis, we
observed a 4-fold increase in histone H4 acetylation at iEk,
upon attenuation of IL-7 signaling (Figure 5B). These data sug-
gest that IL-7 signaling negatively regulates Igk recombination
via repression of iEk activity
Attenuation of IL-7 Signaling Enables E2A Binding
at the Igk Intronic Enhancer
The transcription factor E2A is required for light-chain recombi-
nation and its protein expression has been shown to increase
at the pre-B cell stage (Quong et al., 2004). E2A is required for
iEk activity because a compound mutation of its binding sites
in iEk is functionally equivalent to deletion of the entire enhancer
(Inlay et al., 2004). Therefore, we tested the possibility that IL-7
signaling was negatively regulating Igk recombination via iEk
bymodulating E2A protein expression or binding activity. Neither
E2A protein expression nor DNA binding activity was affected by
attenuating IL-7 signaling in Irf4/Irf8/ pre-B cells (Figure S7).
We next tested whether E2A occupancy of its binding sites in iEk
was negatively regulated by IL-7 signaling by performing ChIP
assays. Strikingly, we observed that although E2A binding
remains constant at the heavy-chain intronic enhancer (Em), it
increased at iEk upon attenuation of IL-7 signaling (Figure 5C).
Consistent with data that E2A binding at 30Ek requires IRF-4
(Lazorchak et al., 2006), we observed no change in E2A occu-
pancy at the 30Ek enhancer. Collectively, these data suggest340 Immunity 28, 335–345, March 2008 ª2008 Elsevier Inc.that IL-7 signaling negatively regulates Igk recombination by
antagonizing E2A binding at the iEk enhancer.
IRF-4 Regulates Cxcr4 Expression and Promotes Pre-B
Cell Migration in Response to CXCL12
Our results raised a developmental conundrum. In vivo, light-
chain recombination is completely dependent on IRF-4,8 (Lu
et al., 2003), whereas in vitro, only one of the two pathways de-
lineated above strictly requires IRF-4. We considered two mutu-
ally nonexclusive possibilities to explain this paradox: (1) IRF-4
upon its induction as a consequence of pre-BCR signaling
antagonizes signaling through the IL-7 receptor, and (2) IRF-4
regulates the expression of chemokine receptors and/or adhe-
sionmolecules that can reposition pre-B cells away from stromal
cells expressing IL-7, thereby attenuating IL-7 signaling. To ex-
plore both possibilities, we performed genome-wide expression
analysis with Irf4/Irf8/ pre-B cells after IRF-4 transduction or
attenuation of IL-7 signaling. This analysis revealed a large set of
genes that were regulated by IL-7 signaling independently of
IRF-4 (Figure S8). Therefore, IRF-4 appears not to antagonize
IL-7 signaling. Consistent with our previous data (Figure 3), Igk
transcripts were more highly induced by IRF-4, whereas attenu-
ation of IL-7 signaling strongly upregulated Rag1 and Rag2
transcripts (Table S1). Interestingly, transcripts for DNA ligase
IV, the enzyme that joins DNA ends during the process of V(D)J
recombination, were also strongly induced by attenuation of
IL-7 signaling (Table S1).
Intriguingly, IRF-4 induced the expression of a number of
genes encoding chemokine receptors and adhesion molecules
(Table S1). Of particular interest was the upregulation of Cxcr4,
the receptor for CXCL12, and this result was confirmed by
Q-PCR (data not shown). CXCL12 is expressed by a distinct
set of bone marrow stromal cells that are spatially separated
from IL-7-expressing stromal cells (Tokoyoda et al., 2004).
Because pre-B cells are not found to be associated with
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CXCL12 (Tokoyoda et al., 2004), migration of pre-B cells toward
a localized source of CXCL12 may provide a mechanism by
which these cells can move away from IL-7 stroma, resulting in
attenuation of IL-7 signaling.We therefore tested, by using trans-
well assays, whether IRF-4 promoted migration of Irf4/Irf8/
pre-B cells to CXCL12. IRF-4-expressing cells showed an
2.5-fold increase inmigration in response to CXCL12 (Figure 6).
These data suggest that IRF-4 regulates the migration of pre-B
cells in the bone marrow, resulting in their movement away
from IL-7-expressing stromal cells. This migration would lead
to the attenuation of IL-7 signaling, thereby enabling the activa-
tion of both pathways that synergistically activate light-chain
recombination (Figure 7).
DISCUSSION
Signaling by the pre-BCR and loss of IL-7 signaling have each
been proposed to regulate light-chain recombination (Geier
and Schlissel, 2006; Grawunder et al., 1993; Milne et al., 2004;
Figure 5. IRF-4 Expression and Attenuation of IL-7 Signaling
Differentially Induce Histone Acetylation and E2A Binding at Ig
Light-Chain Enhancers
Chromatin crosslinking and immunoprecipitation assays (ChIPs) with acety-
lated histone H4 or E2A antibodies in the indicated cell types. Relative enrich-
ment of the bound DNA over input was determined by Q-PCR after normaliza-
tion to a-actin. (A) shows the fold change in H4 acetylation levels at light-chain
enhancers in sorted Irf4/Irf8/ pre-B cells 2 days after IRF-4 transduction
(IRF-4 relative to control). (B) shows the fold change in H4 acetylation levels
at light-chain enhancers upon lowering IL-7 for 1 day (IL-7lo relative to
IL-7hi). As shown in (C), binding of E2A at light-chain enhancers was assessed
in Irf4/Irf8/ pre-B cells cultured in IL-7hi (light-gray bar) or in IL-7lo condi-
tions for 1 (dark-gray bar) or 2 days (black bar). E2A binding to the Em
heavy-chain enhancer was used as a positive control. Data are from three
experiments. Error bars indicate standard deviation.Rolink et al., 2000). However, the evidence with different exper-
imental systems has led to models in which the developmental
activation of light-chain recombination is viewed as either pre-
BCR or IL-7 dependent. Although these data could be inter-
preted as contradictory, another possibility is that parallel or syn-
ergistic pathways promote light-chain recombination such that
interruption of either pathway still permits some level of recom-
bination. In this regard, the Irf4/Irf8/ pre-B cell phenotype
is unique because there is a complete block to light-chain
recombination (Lu et al., 2003). Because these cells express
high levels of the pre-BCR and are strictly dependent on IL-7
for growth in vitro, they provide a distinctive and powerful model
system for assessing the role of these two signaling pathways in
light-chain recombination. By using nontransformed Irf4/Irf8/
pre-B cells, we unequivocally demonstrate that Igk light-chain
recombination can either be directly induced by IRF-4, a regula-
tory factor whose expression is induced by signaling through the
pre-BCR (Muljo and Schlissel, 2003; Thompson et al., 2007), or
by modulation of IL-7 signaling. The two pathways are shown
to differentially regulate the chromatin accessibility of light-chain
loci and the expression of the recombinase genes. IRF-4
appears to coordinate both pathways by regulating migration
of pre-B cells away from stromal cells expressing IL-7, thereby
enabling synergistic induction of light-chain recombination.
Recently, transplantation experiments with Irf4/Irf8/ he-
matopoietic stem cells have been used to confirm that IRF-4
and IRF-8 function in a cell-autonomous manner to regulate
pre-B cell differentiation (Ma et al., 2006). Importantly, the block
in B cell development is not due to a defect in cell survival be-
cause it cannot be rescued by enforced expression of a Bcl2
transgene. Additionally, restoration of either IRF-4 or IRF-8 ex-
pression in Irf4/Irf8/ pre-B cells could induce the generation
of IgM expressing cells. However, these authors restored IRF-4
or 8 expression under conditions involving acute IL-7 withdrawal
and therefore could not distinguish or molecularly analyze the
contributions of the two pathways on light-chain recombination.
Figure 6. IRF-4 Promotes Migration of Irf4/Irf8/ Pre-B Cells in
Response to CXCL12
Migration behavior of Irf4/Irf8/ pre-B cells transduced with a control or
IRF-4 retrovirus in response to medium or 100 ng/ml of CXCL12, 2 days after
transduction. Each transwell assay was performed in duplicate. The average
percentage of input cells that migrated is shown from three independent
experiments. Error bars indicate standard deviation.
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stration of the two pathways (pre-BCR and IL-7) that can function
independently as well as synergistically to regulate light-chain
recombination.
The two convergent pathways act via distinct mechanisms to
enhance the accessibility of the Igk locus and its recombination.
Restoration of IRF-4 resulted in high amounts of Igk germline tran-
scription and preferentially stimulated histone H4 acetylation at
the 30Ek enhancer. These data are compatible with molecular
analyses demonstrating in vivo binding of IRF-4 to 30Ek via a com-
posite Ets-IRF element (Lu et al., 2003) and a requirement for 30Ek
in activating Igk germline transcription (Inlay et al., 2002). In con-
trast, loweringof IL-7signalingpreferentially inducedhistoneacet-
ylation at iEk and robust Rag gene expression. Importantly, the
twopathways function synergistically. Themolecular basis of syn-
ergy in promoting Igk recombination appears to be manifested at
two steps. First, each pathway targets a distinct Igk enhancer and
synergy is likely to be a consequence of simultaneously activating
bothenhancers. Second, IRF-4preferentially induces Igkgermline
transcription,whereas attenuation of IL-7 signalingmore highly in-
duces Rag gene expression, thereby optimizing changes in
accessibility with expression of the recombinase.
Despite the fact that both pathways can promote chromatin
alterations that contribute to Igk locus accessibility, IRF-4 specif-
ically functions to position one Igk allele away from pericentro-
meric heterochromatin. In pre-B cells, one Igk allele is associated
with pericentromeric heterochromatin, and this interaction has
been proposed to impair V(D)J recombination and contribute
to allelic exclusion (Goldmit et al., 2005). Intriguingly, Irf4/
Irf8/ pre-B cells have an increased number of nuclei in which
Figure 7. Integration of Pre-BCR and IL-7R
Signaling Pathways via IRF-4 and the Regu-
lation of Ig Light-Chain Rearrangement in
Pre-B Cells
The regulatory network depicts signaling path-
ways and transcriptional regulators that are re-
quired for light-chain recombination at the pre-B
cell stage. Arrows represent positive regulation,
and barred lines represent repression. IRF-4 plays
a central role in inducing light-chain recombination
downstream of the pre-BCR by directly engaging
the 30Ek and Igl light-chain enhancers. IRF-4 is
proposed to attenuate IL-7 signaling by moving
pre-B cells away from IL-7-expressing stroma as
a consequence of upregulation of the chemokine
receptor Cxcr4. This results in robust induction
of Rag gene expression, E2A binding to iEk, and
synergistic activation of light-chain recombination
by the two pathways.
both Igk alleles are associated with peri-
centromeric heterochromatin. This is in
agreement with the transcriptional inac-
tivity of the germline Igk loci in these cells.
Interestingly, attenuation of IL-7 signaling
does not alter this association pattern,
whereas re-expression of IRF-4 restores
the pattern observed in wild-type cells
that are undergoing light-chain rearrangement. The mechanism
by which IRF-4 positions an Igk allele away from pericentromeric
heterochromatin remains to be determined. One possibility is
that IRF-4 upon binding to an Igk allele repositions it in the nu-
cleus by associating it with an RNA Pol II factory (Ragoczy
et al., 2006), consistentwith the potent activity of IRF-4 in activat-
ing Igk germline transcription. Alternatively, IRF-4 upon binding
induces chromatin-structure alterations that are not compatible
with sustaining an association with pericentromeric heterochro-
matin. Regardless of the mechanism, to our knowledge this is
the first demonstration that a developmentally important tran-
scriptional regulator functions to reposition endogenous target
genes away from pericentromeric heterochromatin.
It has been proposed that the monoallelic activation of an Igk
allele for transcription and recombination is limited by one or
more regulatory factors that interact with the enhancers (Liang
et al., 2004). We propose that IRF-4 is such a developmentally
limiting determinant. Its ability to promote Igk germline transcrip-
tion and recombination as well as repositioning of one but not
both Igk alleles away from pericentromeric heterochromatin is
consistent with this possibility. Furthermore, IRF-4 expression
is upregulated in pre-B cells, and its occupancy at the 30Ek
enhancer increases when cells transition from the pro- to the
pre-B cell stage (Shaffer et al., 1997). We suggest that IRF-4
may also function as a limiting determinant in regulating Igk ver-
sus Igl recombination because it promotes synergy between Igk
but not Igl enhancers.
Although we do not yet fully understand how IL-7 signaling in-
hibits Igk recombination, we demonstrate that IL-7 inhibits the
binding of the transcription factor E2A at iEk. E2A is required342 Immunity 28, 335–345, March 2008 ª2008 Elsevier Inc.
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iEk enhancer activity is critically dependent on E2A (Inlay et al.,
2004). IL-7 signaling does not result in increased E2A protein ex-
pression or DNA binding activity but instead enhances its occu-
pancy at iEk.We note that an enhancer in theRag locus also con-
tains a functional E2A binding site (Hsu et al., 2003). Thus, the
induction of Rag1 gene transcription upon attenuation of IL-7
signaling may be also due to increased binding of E2A at the
Rag locus. We therefore propose that IL-7 signaling functions
in pre-B cells to regulate E2A accessibility at selective target
genes.
IL-7 signaling positively regulates distal VH gene histone acet-
ylation and Igh recombination in pro-B cells via the transcription
factor Stat5 (Bertolino et al., 2005). Paradoxically, we now dem-
onstrate that IL-7 signaling negatively regulates histone acetyla-
tion at iEk and Igk recombination. These analyses lead us to
suggest that IL-7 signaling may be used to developmentally
order Igh and Igk recombination events in B cell development.
According to this model, in pro-B cells, IL-7 signaling would
promote Igh recombination while inhibiting Igk accessibility and
recombination. In pre-B cells, the attenuation of IL-7 signaling
that is associated with the expression and activity of the pre-
BCR would then enable efficient Igk recombination. Importantly,
the cell-cycle arrest that is causedby attenuation of IL-7 signaling
is not sufficient to induce light-chain recombination. We demon-
strate that IL-7 signaling is also a potent negative regulator ofRag
gene expression in pre-B cells. Thus, attenuation of IL-7 signaling
functions to induce Igk locus accessibility, recombinase gene
expression, and recombination of Igk alleles in pre-B cells. Be-
cause the pre-TCR regulates the transition from pre-T to T cell
and its expression is coupled to attenuation of IL-7 signaling
(Van DeWiele et al., 2004), we propose thatRag gene expression
and the promotion of TCRa rearrangement may also be ensured
by a combination of acquired pre-TCR and attenuated IL-7
signaling.
Our proposal that attenuation of IL-7 signaling contributes to the
developmental ordering of immunoglobulin gene recombination is
consistent with the anatomic distribution of pro-B and pre-B
cells in the bone marrow. Pro-B cells are associated with IL-7-
expressing stroma while pre-B cells are positioned away from
such niches (Tokoyoda et al., 2004). Because the IL-7 receptor
is not downregulated at the pre-B stage (Rolink et al., 2000),
the positioning of pre-B cells away from IL-7-expressing stromal
cells would provide a mechanism for the attenuation of IL-7
signaling. We now demonstrate that IRF-4 upregulates the ex-
pression of the chemokine receptorCxcr4 in pre-B cells and pro-
motes migration toward a source of CXCL12. CXCR4 is required
for early B cell development and is the sole physiological recep-
tor for CXCL12 (Zou et al., 1998). CXCL12 is expressed on bone
marrow stromal cells that are spatially separated from IL-7-ex-
pressing stromal cells (Tokoyoda et al., 2004). We suggest
that IRF-4-dependent enhanced chemotaxis toward CXCL12
expressing stomal cells results in repositioning of pre-B cells
from the IL-7-expressing stroma and drives their differentiation
by the synergistic induction of light-chain recombination utilizing
the two pathways delineated above. Intriguingly, attenuation of
IL-7 signaling also upregulates Cxcr4 expression and enhances
migration toward CXCL12 (data not shown). Therefore, we sug-
gest that altered chemotaxis of pre-B cells induced by IRF-4would be amplified by attenuation of IL-7 signaling through
a positive-feedback regulatory loop. Although, pre-B cells have
increased migration toward CXCL12, they do not adhere via
VCAM-1 in response to CXCL12 (Tokoyoda et al., 2004). There-
fore, it is possible that migrating pre-B cells do not sustain con-
tact with CXCL12 expressing stromal cells, consistent with the
fact that they are not found to be highly associated with
CXCL12 stroma in vivo.
We suggest that IRF-4,8 are a pivotal node of a regulatory cir-
cuit that drives light-chain recombination and the transition from
a pre-B to B cell. Pre-B cells proliferate in response to the pre-
BCR and the IL-7 receptor (IL-7R). Pre-BCR signals upregulate
IRF-4, which downregulates the surrogate light-chain genes,
and eventually surface pre-BCR expression (Thompson et al.,
2007). Concomitantly, IRF-4 engages the 30Ek and the Igl en-
hancers and initiates light-chain recombination. IRF-4 by upre-
gulating Cxcr4 causes pre-B cells to move away from IL-7-ex-
pressing stroma, thereby attenuating IL-7 signaling. This
results in activation of iEk via binding of E2A as well as optimal
expression of Rag genes. Thus, IRF-4 coordinates pre-BCR
and IL-7 signaling, thereby enabling activation of light-chain re-
arrangement by two distinct molecular pathways in pre-B cells.
EXPERIMENTAL PROCEDURES
Mice
The Irf4/Irf8/ andCcnd3/mice have been previously described (Cooper
et al., 2006; Lu et al., 2003). Mice were housed in specific pathogen-free
conditions and were maintained and used in accordance with the Institutional
Animal Care and Use Committee guidelines.
Cells and Culture Conditions
Irf4/Irf8/ bonemarrow cells were isolated and positively selected for CD19
with a biotin-coupled antibody; this was followed by binding to Streptavidin
microbeads (Miltenyi Biotec). Cells were cultured in Optimem media supple-
mented with 5% FCS and 5 ng/ml of IL-7 (IL-7hi) on OP9 stromal cells. Cells
were typically >99%CD19+pre-BCR+. IL-7 signaling was attenuated by cultur-
ing in media containing 0.1 ng/ml of IL-7 (IL-7lo).
DNA Constructs
The murine IRF-4 retroviral construct has been described previously (Sciam-
mas et al., 2006). The p27 retroviral construct was a kind gift of S. Winandy
(Northwestern University).
RT-PCR
Total RNA was isolated with Trizol (Invitrogen) and cDNA was made with
SuperScript II reverse transcriptase (Invitrogen). Quantitative PCR was per-
formed in triplicate with a SYBR green kit (Stratagene) with gene-specific
primers (Table S2).
PCR Analysis of Igk Rearrangements
PCR with genomic DNA was performed as described (Inlay et al., 2002)
(primers ‘‘a’’ and ‘‘b’’ in Figure 1; Table S2). We amplified a nonrecombined re-
gion to control for the amount of DNA (primers ‘‘a’’ and ‘‘c’’ in Figure 1; Table
S2). PCR products were separated by gel electrophoresis, transferred to Hy-
bond-N membranes (Amersham), and quantitatively analyzed on a Phosphor-
imager after Southern blotting. Quantitative analysis was performed by Q-PCR
(primers ‘‘a’’ and ‘‘d’’ in Figure 1; Table S2). We used iEk primers (primers ‘‘e’’
and ‘‘f’’ in Figure 1; Table S2) to control for the amount of DNA.
Chromatin Immunoprecipitation Assays
Chromatin immunoprecipitation assays (ChIP) analysis of acetylated histones
and E2A were performed essentially as previously described (Bertolino et al.,
2005; Deleuze et al., 2007). ChIP PCRprimers are listed in Table S2. AntibodiesImmunity 28, 335–345, March 2008 ª2008 Elsevier Inc. 343
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Biotechnology), control Ig (sc-2027; Santa Cruz), and E47 antibodies (sc-763
and sc-416; Santa Cruz).
Electrophoretic Mobility-Shift Assays
Nuclear extracts were prepared and assayed with E2A binding site oligonucle-
otide probes as described previously (Kee and Murre, 1998). The DNA probes
used are listed in Table S2.
Retroviral Transduction of Irf4/Irf8/ Cells
PlatE packaging cells were transiently transfected with retroviral constructs
with the Fugene reagent (Roche). Viral supernatants were collected 48 hr
and 72 hr after transduction. Irf4/Irf8/ cells were suspended in retroviral
supernatant with 8 mg/ml polybrene in the presence of IL-7 (5 ng/ml) and centri-
fuged at 2200 rpm for 2 hr at room temperature. Cells were incubated at 32C
for 2–4 hr and then were washed and plated on OP9 cells in the presence of
5 ng/ml of IL-7.
Immunoblotting
Protein extracts were prepared as previously described (Cooper et al., 2006).
Protein lysates from equivalent cell numbers were separated by SDS-PAGE
and transferred to Immobilion-P membranes (Millipore). Protein blots were
probed with antibodies to cyclin D2 (M-20; Santa Cruz), cyclin D3 (C-16; Santa
Cruz), p27 (sc-1641; Santa Cruz), E47 (554077; Becton Dickinson), or Stat5
(sc-835; Santa Cruz). Either actin (MAB1501; Chemicon International) or
HPRT (sc-20975; Santa Cruz) was used as an internal control.
Three-Dimensional DNA FISH
Three-dimensional DNA-FISH experiments were performed as previously de-
scribed (Skok et al., 2001) The Igk DNA probes were generated from BACs
101G13 (Vk24) and 387E13 (Igk constant region) in combination with a g-sat-
ellite probe. Probes were directly labeled by nick translation with dUTP-Cy3 or
dUTP-A488 (Invitrogen). The g-satellite probe (Skok et al., 2001) was labeled
with dUTP-Cy5 (GE Healthcare). Cells were analyzed by confocal microscopy
on a Leica Sp5 AOBS (Acoustica Optical Beam Splitter) system. Optical sec-
tions separated by 0.3 mmwere collected, and only cells with signals from both
alleles (typically 95%) were analyzed.
Flow Cytometry
Surface staining and intracellular staining has been described previously
(Sciammas et al., 2006). Antibodies specific for murine CD19 (1D3) and IgM
(II/41) were from BD PharMingen. For cell-cycle analysis, cells were stained
with 10 mg/ml Hoechst 33342 (Molecular probes) in media at 37C for
60 min. Cells transduced cells with p27-IRES-H-2Kk retroviral vectors were
prestainedwith PE anti-mouse H-2Kk (36-7-5; BD PharMingen). Data were col-
lected with the FACS Calibur flow cytometer or the LSR II and were analyzed
with FlowJo software (Tree Star).
Microarray Analysis
Total RNA was isolated from Irf4/Irf8/ cells cultured in high IL-7 (5 ng/ml)
and shifted to low IL-7 (0.1 ng/ml) for 1 day. IRF-4-transduced cells were
sorted and maintained in high IL-7 for 2 days before RNA isolation. Triplicates
of each cell sample were used in the analysis. Biotin-labeled cRNAwas hybrid-
ized to mouse Genome 430 2.0 Array according to manufacturer’s instructions
as described previously (Laslo et al., 2006). Expression levels of select genes
were confirmed by Q-PCR.
Cell-Migration Assays
Migration assays were performed as described previously (Reif et al., 2002). A
total of 0.3 to 1 3 106 cells/100 ul were placed in the upper compartment of
a transwell chamber (5 um pore size, Corning) with 600 ul of medium contain-
ing 100 ng/ml of CXCL12 (Sigma). The number of cells that migrated into the
lower chamber was measured by flow cytometry after 2 hr and expressed
relative to the number of input cells. All assays were performed in duplicate.344 Immunity 28, 335–345, March 2008 ª2008 Elsevier Inc.ACCESSION NUMBERS
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